Видео ютуба по тегу Idelalisib

Idelalisib in Chronic Lymphocytic Leukemia
Idelalisib in Chronic Lymphocytic Leukemia
Understanding the Trial With Idelalisib and Rituximab
Understanding the Trial With Idelalisib and Rituximab
Side-effect of idelalisib and its use in chronic lymphocytic leukemia
Side-effect of idelalisib and its use in chronic lymphocytic leukemia
What are the risks and benefits of Ibrutinib and Idelalisib?
What are the risks and benefits of Ibrutinib and Idelalisib?
Idelalisib for Previously Treated CLL
Idelalisib for Previously Treated CLL
Approaches to overcome side effects of idelalisib for follicular lymphoma
Approaches to overcome side effects of idelalisib for follicular lymphoma
Idelalisib for Follicular Lymphoma
Idelalisib for Follicular Lymphoma
CLL: Idelalisib based regimens
CLL: Idelalisib based regimens
Dr. Jeffrey Jones on Idelalisib and Ibrutinib in Patients With CLL
Dr. Jeffrey Jones on Idelalisib and Ibrutinib in Patients With CLL
Dr. Jeffrey Jones on Efficacy of Idelalisib/Ofatumumab Combination in CLL
Dr. Jeffrey Jones on Efficacy of Idelalisib/Ofatumumab Combination in CLL
Dr. Furman on the Efficacy and Safety of Idelalisib and Rituximab for Previously Treated CLL
Dr. Furman on the Efficacy and Safety of Idelalisib and Rituximab for Previously Treated CLL
Safety profiles of idelalisib, duvelisib and TGR-1202 in treating CLL
Safety profiles of idelalisib, duvelisib and TGR-1202 in treating CLL
About Targeted Therapy Zydelig (Idelalisib)
About Targeted Therapy Zydelig (Idelalisib)
What are the risks and benefits of both ibrutinib and Idelalisib?
What are the risks and benefits of both ibrutinib and Idelalisib?
Dr. Kipps on Ibrutinib and Idelalisib For CLL
Dr. Kipps on Ibrutinib and Idelalisib For CLL
Treatment of haematological malignancies with idelalisib
Treatment of haematological malignancies with idelalisib
CLL: Long-term updates on ibrutinib and idelalisib
CLL: Long-term updates on ibrutinib and idelalisib
Side effects of idelalisib in CLL and how to manage them
Side effects of idelalisib in CLL and how to manage them
The risk of infection for CLL patients receiving idelalisib
The risk of infection for CLL patients receiving idelalisib
Dr. Furman on Using Idelalisib Instead of Chemotherapy to Treat CLL
Dr. Furman on Using Idelalisib Instead of Chemotherapy to Treat CLL
Dr. Richard Furman on Avoiding Chemotherapy With Idelalisib
Dr. Richard Furman on Avoiding Chemotherapy With Idelalisib
Dr. Jeffrey Jones on Idelalisib Combinations in CLL
Dr. Jeffrey Jones on Idelalisib Combinations in CLL
Real-world evidence of venetoclax vs ibrutinib vs idelalisib
Real-world evidence of venetoclax vs ibrutinib vs idelalisib
Drug combinations in CLL: ibrutinib, idelalisib and more
Drug combinations in CLL: ibrutinib, idelalisib and more
Dr. Jennifer Brown on Ibrutinib, Idelalisib, and Other Agents for CLL
Dr. Jennifer Brown on Ibrutinib, Idelalisib, and Other Agents for CLL